Selank Protects Rat Liver from Stress-Induced Damage and Oxidative Stress
Background
Chronic stress can significantly impact organ function, particularly the liver, leading to hepatocyte (liver cell) damage and oxidative stress due to an imbalance between free radicals and antioxidants. Such damage can manifest as elevated liver enzymes and impaired detoxification processes. While various compounds have been explored for their stress-protective effects, the specific impact of the anxiolytic peptide Selank on liver function and oxidative markers under conditions of restraint stress has remained largely uninvestigated. This study aimed to evaluate Selank's ability to mitigate liver damage and oxidative stress in rats subjected to acute and chronic restraint stress.
Results
Under conditions of acute restraint stress, Selank demonstrated significant hepatoprotective and antioxidant effects. Specifically, doses of 100 μg/kg and 300 μg/kg led to a decrease in catalase and superoxide dismutase (SOD) activities, a reduction in malondialdehyde (MDA) concentration (a marker of lipid peroxidation), and an increase in total antioxidant activity within the liver homogenate, indicating reduced oxidative damage compared to stressed controls. > The most pronounced effect under acute stress was observed with Selank at 1000 μg/kg, which significantly reduced the content of aminotransferases (AST and ALT) in blood serum, decreased superoxide dismutase activity in the liver, and notably increased total antioxidant activity, suggesting a comprehensive protective effect against stress-induced liver injury. Under chronic stress conditions, Selank in all tested doses (100, 300, and 1000 μg/kg) produced consistent beneficial effects: it reduced superoxide dismutase activity and malondialdehyde concentration in the liver tissue, and decreased AST activity in the serum, while other measured parameters remained stable. These findings collectively highlight Selank's ability to mitigate oxidative stress and liver enzyme elevation induced by both acute and chronic psychological stressors.
Why It Matters
This study provides compelling evidence that Selank possesses significant hepatoprotective and antioxidant properties, effectively shielding the liver from the damaging effects of both acute and chronic restraint stress. The observed reductions in liver enzymes and oxidative stress markers suggest that Selank could be a valuable therapeutic agent for conditions where psychological stress contributes to liver dysfunction or damage. This research indicates a novel application for Selank beyond its known anxiolytic effects, potentially offering a new strategy for managing stress-induced organ pathology. Future research should explore Selank's potential in human clinical trials for stress-related liver conditions, such as non-alcoholic fatty liver disease (NAFLD) exacerbated by stress, or other forms of stress-induced hepatic injury. Further mechanistic studies are also warranted to fully elucidate the pathways through which Selank exerts these beneficial effects.